Pressure BioSciences, Inc. (PBIO)
USD 0.01
(33.33%)
USD 0.01
(33.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 161.86 Thousand USD | -44.17% |
| 2022 | 289.92 Thousand USD | -29.73% |
| 2021 | 412.56 Thousand USD | -39.62% |
| 2020 | 683.27 Thousand USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 136.38 Thousand USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 655.26 Thousand USD | 269.49% |
| 2015 | 177.34 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 2.27 Million USD | -2.85% |
| 2002 | 2.33 Million USD | -2.7% |
| 2001 | 2.4 Million USD | -54.13% |
| 2000 | 5.23 Million USD | -26.21% |
| 1999 | 7.1 Million USD | 77.5% |
| 1998 | 4 Million USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 161.18 Thousand USD | -0.42% |
| 2023 Q4 | 161.86 Thousand USD | -30.77% |
| 2023 FY | 161.86 Thousand USD | -44.17% |
| 2023 Q1 | 253.89 Thousand USD | -12.43% |
| 2023 Q2 | 244.08 Thousand USD | -3.86% |
| 2023 Q3 | 233.8 Thousand USD | -4.21% |
| 2022 Q3 | 321.91 Thousand USD | -8.8% |
| 2022 Q4 | 289.92 Thousand USD | -9.94% |
| 2022 FY | 289.92 Thousand USD | -29.73% |
| 2022 Q1 | 383.19 Thousand USD | -7.12% |
| 2022 Q2 | 352.99 Thousand USD | -7.88% |
| 2021 Q2 | 647.64 Thousand USD | -2.72% |
| 2021 Q3 | 629.01 Thousand USD | -2.88% |
| 2021 Q1 | 665.72 Thousand USD | -2.57% |
| 2021 FY | 412.56 Thousand USD | -39.62% |
| 2021 Q4 | 412.56 Thousand USD | -34.41% |
| 2020 Q3 | 527.03 Thousand USD | 0.0% |
| 2020 FY | 683.27 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q2 | 527.03 Thousand USD | 0.0% |
| 2020 Q4 | 683.27 Thousand USD | 29.64% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q1 | 59.17 Thousand USD | -56.61% |
| 2019 Q2 | 40.65 Thousand USD | -31.3% |
| 2019 Q3 | - USD | -100.0% |
| 2019 FY | - USD | -100.0% |
| 2018 FY | 136.38 Thousand USD | 0.0% |
| 2018 Q4 | 136.38 Thousand USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q1 | 5425.00 USD | -99.17% |
| 2017 FY | - USD | -100.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q3 | 1.07 Million USD | -45.22% |
| 2016 Q2 | 1.96 Million USD | 95.48% |
| 2016 Q4 | 655.26 Thousand USD | -39.24% |
| 2016 Q1 | 1 Million USD | 467.87% |
| 2016 FY | 655.26 Thousand USD | 269.49% |
| 2015 Q4 | 177.34 Thousand USD | -56.99% |
| 2015 Q3 | 412.32 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | 177.34 Thousand USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q4 | - USD | -100.0% |
| 2013 Q2 | 12.38 Thousand USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q3 | 100 Thousand USD | 707.49% |
| 2013 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 100.0% |
| 2007 Q1 | -557.16 Thousand USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q2 | - USD | -100.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | 2.25 Million USD | -0.76% |
| 2003 Q4 | 2.27 Million USD | -0.75% |
| 2003 Q1 | 2.32 Million USD | -0.67% |
| 2003 Q2 | 2.29 Million USD | -1.17% |
| 2003 Q3 | 2.28 Million USD | -0.3% |
| 2003 FY | 2.27 Million USD | -2.85% |
| 2002 Q4 | 2.33 Million USD | 0.22% |
| 2002 Q1 | 2.39 Million USD | -0.33% |
| 2002 FY | 2.33 Million USD | -2.7% |
| 2002 Q2 | 2.34 Million USD | -2.22% |
| 2002 Q3 | 2.33 Million USD | -0.38% |
| 2001 Q2 | 2.39 Million USD | -0.48% |
| 2001 Q1 | 2.4 Million USD | -54.04% |
| 2001 FY | 2.4 Million USD | -54.13% |
| 2001 Q4 | 2.4 Million USD | 0.75% |
| 2001 Q3 | 2.38 Million USD | -0.46% |
| 2000 Q3 | 5.08 Million USD | 100.17% |
| 2000 Q1 | - USD | -100.0% |
| 2000 FY | 5.23 Million USD | -26.21% |
| 2000 Q4 | 5.23 Million USD | 3.0% |
| 2000 Q2 | 2.54 Million USD | 0.0% |
| 1999 Q2 | 5.6 Million USD | 5.66% |
| 1999 FY | 7.1 Million USD | 77.5% |
| 1999 Q1 | 5.3 Million USD | 32.5% |
| 1999 Q3 | 6.2 Million USD | 10.71% |
| 1999 Q4 | 7.1 Million USD | 14.52% |
| 1998 Q2 | 500 Thousand USD | 0.0% |
| 1998 FY | 4 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q4 | 4 Million USD | 344.44% |
| 1998 Q3 | 900 Thousand USD | 80.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | -100.0% |
| 1997 Q1 | 4 Million USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | -100.0% |
| 1996 Q3 | 3.5 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | 98.708% |
| IR-Med Inc. | 161 Thousand USD | -0.537% |
| Polarean Imaging plc | 74.84 Thousand USD | -116.263% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -39.473% |
| Avitar, Inc. | 3.89 Million USD | 95.846% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 63.989% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.948% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 99.142% |
| Össur hf. | 311.8 Million USD | 99.948% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 73.808% |
| Escalon Medical Corp. | 279.4 Thousand USD | 42.068% |
| Aurora Spine Corporation | 1.59 Million USD | 89.831% |
| BrainsWay Ltd. | 239 Thousand USD | 32.274% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 99.031% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.98% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | 25.618% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -270.602% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 72.565% |
| Nanomix Corporation | 10.11 Million USD | 98.399% |
| Theraclion SA | 1.95 Million EUR | 91.702% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 46.86% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -7.909% |
| Lombard Medical, Inc. | 28.02 Million USD | 99.422% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.819% |
| Vycor Medical, Inc. | 243.28 Thousand USD | 33.468% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -13.725% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 67.101% |
| VMS Rehab Systems, Inc. | 106.45 USD | -151956.364% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 68.324% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 69.59% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 79.868% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 49.794% |
| Urologix, Inc. | 4.58 Million USD | 96.47% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 62.378% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 94.191% |
| SS Innovations International, Inc. | 1.91 Million USD | 91.527% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.993% |
| NIOX Group Plc | 500 Thousand USD | 67.627% |
| Fuse Medical, Inc. | 200 Thousand USD | 19.068% |
| Broncus Holding Corporation | 1.22 Million USD | 86.776% |
| Brain Scientific Inc. | 7378.00 USD | -2093.874% |
| Health Logic Interactive Inc. | - USD | -Infinity% |